Brain Atrophy in a Murine Model of Chronic Fatigue Syndrome and Beneficial Effect of Hochu-ekki-to (TJ-41)

Brain-derived neurotrophic factor (BDNF) is associated with the main symptoms of chronic fatigue sydrome (CFS) and neuron apoptosis. Nevertheless, no study has been performed directly to explore the relationship between CFS, BDNF and neuron apoptosis. We induced a CFS model by six injections of killed Brucella abortus antigen in BALB/c mice and treated them with Hochu-ekki-to (TJ-41). Daily running activity, body weight (BW), ratio of cerebral weight to BW (CW/BW) and expression levels of BDNF and Bcl-2 mRNA in the hippocampus were determined. The daily activity and CW/BW decreased significantly in the CFS model. BDNF and Bcl-2 mRNA expression levels in the hippocampus were suppressed in the CFS model and TJ-41 treated mice, while no significant difference was found between them. We improved a murine model to investigate the relationship between CFS and brain dysfunction. In this model, reduced daily activity might have been associated with decreased hippocampal BDNF mRNA expression, hippocampal apoptosis and brain atrophy. TJ-41 increased the daily running activity of the model, which was independent of brain recovery.

[1]  W. Tarello.  Chronic fatigue syndrome (CFS) associated with Staphylococcus spp. bacteremia, responsive to potassium arsenite 0.5% in a veterinary surgeon and his coworking wife, handling with CFS animal cases. , 2001, Comparative immunology, microbiology and infectious diseases.

[2]  B. Christie,et al.  Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male sprague–dawley rats in vivo , 2004, Neuroscience.

[3]  I. Hickie,et al.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.

[4]  T. Kanda,et al.  Beneficial Effect of Brewers' Yeast Extract on Daily Activity in a Murine Model of Chronic Fatigue Syndrome , 2006, Evidence-based complementary and alternative medicine : eCAM.

[5]  H. Okano,et al.  Bcl2 enhances survival of newborn neurons in the normal and ischemic hippocampus , 2006, Journal of neuroscience research.

[6]  J. Meer.  CHRONIC FATIGUE SYNDROME , 1997 .

[7]  C. Laske,et al.  Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. , 2007, Journal of psychiatric research.

[8]  F. Gomez-Pinilla,et al.  Suppression of hippocampal plasticity‐related gene expression by sleep deprivation in rats , 2006, The Journal of physiology.

[9]  F. Gomez-Pinilla,et al.  The select action of hippocampal calcium calmodulin protein kinase II in mediating exercise-enhanced cognitive function , 2007, Neuroscience.

[10]  Norihiro Sadato,et al.  Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome , 2004, BMC neurology.

[11]  Zhe Ying,et al.  Differential effects of acute and chronic exercise on plasticity‐related genes in the rat hippocampus revealed by microarray , 2002, The European journal of neuroscience.

[12]  T. Konishi,et al.  Antioxidant potential of qizhu tang, a chinese herbal medicine, and the effect on cerebral oxidative damage after ischemia reperfusion in rats. , 2001, Biological & pharmaceutical bulletin.

[13]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.

[14]  J. Kimura,et al.  Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain , 1996, Neuroscience.

[15]  B. Natelson,et al.  Patients with chronic fatigue syndrome have reduced absolute cortical blood flow , 2006, Clinical physiology and functional imaging.

[16]  J. Fudge.  Bcl-2 immunoreactive neurons are differentially distributed in subregions of the amygdala and hippocampus of the adult macaque , 2004, Neuroscience.

[17]  S. Chiou,et al.  Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway , 2008, European Neuropsychopharmacology.

[18]  S. Chen,et al.  Anti-aging effects of the traditional Chinese medicine bu-zhong-yi-qi-tang in mice. , 2000, The American journal of Chinese medicine.

[19]  Daniel P. Redmond,et al.  Core body temperature is normal in chronic fatigue syndrome , 1998, Biological Psychiatry.

[20]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[21]  B. Natelson,et al.  Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. , 1998, The American journal of medicine.

[22]  H. Thoenen,et al.  Purification of a new neurotrophic factor from mammalian brain. , 1982, The EMBO journal.

[23]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[24]  C. Cotman,et al.  Estrogen and exercise interact to regulate brain‐derived neurotrophic factor mRNA and protein expression in the hippocampus , 2001, The European journal of neuroscience.

[25]  F. Corrigan,et al.  Neurasthenic fatigue, chemical sensitivity and GABAa receptor toxins. , 1994, Medical hypotheses.

[26]  G. Bleijenberg,et al.  Chronic fatigue syndrome , 2006, The Lancet.

[27]  M. Mishina,et al.  Enhancement of neurogenesis by running wheel exercises is suppressed in mice lacking NMDA receptor epsilon 1 subunit. , 2003, Neuroscience research.

[28]  H. Manji,et al.  New insights into BDNF function in depression and anxiety , 2007, Nature Neuroscience.

[29]  F. Murray,et al.  Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists. , 2007, European journal of pharmacology.

[30]  Rosane Nisenbaum,et al.  Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution , 2003, BMC health services research.

[31]  B. Natelson,et al.  Mouse Running Activity Is Lowered by Brucella abortus Treatment: A Potential Model to Study Chronic Fatigue , 1998, Physiology & Behavior.

[32]  Jason Steffener,et al.  Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: A BOLD fMRI study of verbal working memory , 2005, NeuroImage.

[33]  Ivan Toni,et al.  Gray matter volume reduction in the chronic fatigue syndrome , 2005, NeuroImage.

[34]  F. Gomez-Pinilla,et al.  A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor , 2003, Neuroscience.

[35]  H. Schmidt,et al.  The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior , 2007, Behavioural pharmacology.

[36]  H. Haas,et al.  Temporal pattern of hippocampal high-frequency oscillations during sleep after stimulant-evoked waking , 2003, Neuroscience.

[37]  K. Kotulska,et al.  BDNF contributes to animal model neuropathic pain after peripheral nerve transection , 2007, Neurosurgical Review.

[38]  F. Gage,et al.  Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus , 1999, Nature Neuroscience.

[39]  T. Kanda,et al.  Effect of Hochu-ekki-to (TJ-41), a Japanese Herbal Medicine, on Daily Activity in a Murine Model of Chronic Fatigue Syndrome , 2004, Evidence-based complementary and alternative medicine : eCAM.

[40]  N. McGregor,et al.  Possible Triggers and Mode of Onset of Chronic Fatigue Syndrome , 2002 .

[41]  C. Cotman,et al.  Exercise and brain neurotrophins , 1995, Nature.

[42]  Jason Steffener,et al.  Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls , 2007, NeuroImage.

[43]  D. Bredesen,et al.  bcl-2 inhibits death of central neural cells induced by multiple agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Mishina,et al.  Enhancement of neurogenesis by running wheel exercises is suppressed in mice lacking NMDA receptor ε1 subunit , 2003, Neuroscience Research.

[45]  T. Yasuhara,et al.  Lack of exercise, via hindlimb suspension, impedes endogenous neurogenesis , 2007, Neuroscience.

[46]  Hui Li Li,et al.  The novel neurotrophin‐regulated neuronal development‐associated protein, NDAP, mediates apoptosis , 2006, FEBS letters.